摘要 |
<p>It is intended to provide 5-thio-beta-D-glucopyranoside compounds represented by the following general formula (i), which show an effect of inhibiting the SGLT2 activity, pharmaceutically acceptable salts thereof or hydrates of the same; and drugs (in particular, preventives or remedies for diabetes, diseases relating to diabetes or diabetic complications) containing the same as the active ingredient: (i).</p> |